FibroBiologics, Inc. Common Stock

NASDAQ (USD): FibroBiologics, Inc. Common Stock (FBLG)

Last Price

0.93

Today's Change

-0.09 (8.82%)

Day's Change

0.894 - 0.99

Trading Volume

99,562

Overview

Market Cap

35 Million

Shares Outstanding

38 Million

Avg Volume

208,735

Avg Price (50 Days)

1.01

Avg Price (200 Days)

2.03

PE Ratio

-2.75

EPS

-0.34

Earnings Announcement

13-May-2025

Previous Close

1.02

Open

0.99

Day's Range

0.9124 - 0.9599

Year Range

0.763 - 13.59

Trading Volume

171,152

Price Change Highlight

1 Day Change

-8.42%

5 Day Change

6.45%

1 Month Change

-21.50%

3 Month Change

-20.84%

6 Month Change

-63.79%

Ytd Change

-53.06%

1 Year Change

-91.77%

3 Year Change

-96.79%

5 Year Change

-96.79%

10 Year Change

-96.79%

Max Change

-96.79%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

FibroBiologics, Inc., a clinical-stage cell therapy company, develops and commercializes fibroblast-based therapies in the United States. It is developing CybroCell, for the treatment of degenerative disc disease; CYMS101 to treat multiple sclerosis; and CYWC628 for wound healing. The company is also on the early-stage research of CYTER915, which is designed to regenerate or reinvigorate production of the thymus and/or spleen; CYPS317, for the treatment of psoriasis; and TCB190 to treat certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment